Pfizer (PFE) Stock Today: Price, Metsera Obesity Deal, 2025–2026 Forecast and Key Risks
Pfizer, Inc. (NYSE: PFE) is back in focus on December 5, 2025, as investors weigh a near‑7% dividend yield, fresh analyst commentary, a major obesity‑drug acquisition and a slate of upcoming guidance that will shape expectations for 2026. Below is a detailed, news‑driven look at Pfizer stock today, including the latest price action, current Wall Street forecasts, and the biggest opportunities and risks now dominating the conversation. Pfizer stock price today: where things stand As of late trading on December 5, 2025, Pfizer shares are: Volatility is relatively low: one recent analysis pegs Pfizer’s rolling one‑year beta at just 0.59,